Attached files
file | filename |
---|---|
10-K - FORM 10-K - GENOMIC HEALTH INC | f58029e10vk.htm |
EX-21.1 - EX-21.1 - GENOMIC HEALTH INC | f58029exv21w1.htm |
EX-12.1 - EX-12.1 - GENOMIC HEALTH INC | f58029exv12w1.htm |
EX-31.1 - EX-31.1 - GENOMIC HEALTH INC | f58029exv31w1.htm |
EX-32.2 - EX-32.2 - GENOMIC HEALTH INC | f58029exv32w2.htm |
EX-31.2 - EX-31.2 - GENOMIC HEALTH INC | f58029exv31w2.htm |
EX-23.1 - EX-23.1 - GENOMIC HEALTH INC | f58029exv23w1.htm |
EX-10.14 - EX-10.14 - GENOMIC HEALTH INC | f58029exv10w14.htm |
EX-10.13 - EX-10.13 - GENOMIC HEALTH INC | f58029exv10w13.htm |
EX-10.15 - EX-10.15 - GENOMIC HEALTH INC | f58029exv10w15.htm |
EXHIBIT 32.1
STATEMENT OF CHIEF EXECUTIVE OFFICER UNDER 18 U.S.C. § 1350
I, Kimberly J. Popovits, the chief executive officer of Genomic Health, Inc. (the Company),
certify for the purposes of section 1350 of chapter 63 of title 18 of the United States Code that,
to the best of my knowledge,
(i) the Annual Report of the Company on Form 10-K for the period ended December 31, 2010 (the
Report), fully complies with the requirements of section 13(a) of the Securities Exchange Act of
1934, and
(ii) the information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
/s/ Kimberly
J. Popovits |
||||
Chief Executive Officer | ||||
March 11, 2011 |